Standard Biotools Inc. SEC filings LAB
Standard Biotools Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 30, 2026 | — |
| 424B3 | Prospectus | Oct 21, 2026 | — |
| S-4/A | Filing | Oct 21, 2026 | — |
| S-4/A | Filing | Oct 9, 2026 | — |
| S-4/A | Filing | Sep 9, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 20, 2026 | — |
| S-8 | Employee stock plan registration | Aug 15, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-3 | Shelf registration | Jun 20, 2024 | — |
| S-3/A | Filing | Feb 2, 2024 | — |
| S-3 | Shelf registration | Jan 19, 2024 | — |
| S-3 | Shelf registration | Jan 19, 2024 | — |
| S-8 | Employee stock plan registration | Jan 19, 2024 | — |
| S-8 | Employee stock plan registration | Jan 19, 2024 | — |
| 424B3 | Prospectus | Dec 22, 2023 | — |
| 424B3 | Prospectus | Dec 1, 2023 | — |
| S-4/A | Filing | Dec 1, 2023 | — |
| S-4 | Registration for a merger or exchange | Nov 14, 2023 | — |
| S-8 | Employee stock plan registration | Jun 20, 2023 | — |
| 424B3 | Prospectus | May 27, 2022 | — |
| S-3 | Shelf registration | May 17, 2022 | — |
| S-8 | Employee stock plan registration | Apr 1, 2022 | — |
| S-8 | Employee stock plan registration | May 28, 2021 | — |
| S-8 | Employee stock plan registration | Jul 10, 2020 | — |
| 424B5 | Prospectus supplement | Mar 5, 2020 | — |
| POS AM | Filing | Feb 27, 2020 | — |
| S-8 | Employee stock plan registration | Jun 28, 2019 | — |
| S-3ASR | Automatic shelf registration | Mar 18, 2019 | — |
| S-8 | Employee stock plan registration | Jan 11, 2019 | — |
| 424B5 | Prospectus supplement | Dec 12, 2018 | — |
| 424B5 | Prospectus supplement | Dec 11, 2018 | — |
| S-8 | Employee stock plan registration | Jan 16, 2018 | — |
| 424B5 | Prospectus supplement | Aug 11, 2017 | — |
| S-8 | Employee stock plan registration | Aug 3, 2017 | — |
| 424B5 | Prospectus supplement | Aug 3, 2017 | — |
| S-3/A | Filing | Apr 28, 2017 | — |
| S-3 | Shelf registration | Mar 8, 2017 | — |
| S-8 | Employee stock plan registration | Jan 13, 2017 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1162194
- Former names
- FLUIDIGM CORP (until Apr 1, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.